Nederlandse studie naar de beste behandelstrategie bij patiënten met een eerste of tweede oesofagus- of maagvaricesbloeding: De TIPS-TRUE-trial

Translated title of the contribution: Dutch study on the optimal treatment strategy for patients with a first or second occurrence of gastro-oesophageal variceal bleeding: The TIPS-TRUE trial

H. R. Van Buuren, A. Wils, E. A.J. Rauws, B. Van Hoek, J. P.H. Drenth, E. J. Kuipers, P. M.T. Pattynama

Research output: Contribution to journalShort surveypeer-review

2 Citations (Scopus)

Abstract

The main options for secondary prevention of gastrooesophageal variceal bleeding are endoscopic therapy and treatment with propranolol. Creation of a transjugular intrahepatic portosystemic shunt (TIPS) is currently considered a valuable secondary 'rescue' treatment when other therapies fail. Recent data suggest that the use of covered stents markedly increases the efficacy of TIPS, compared with conventional uncovered stents. Therefore, a multicentre randomised trial was designed to compare the effects of TIPS using covered stents with those of endoscopic therapy plus propranolol in patients with a first or second episode of gastro-oesophageal variceal bleeding. TIPS will be performed in 4 university centres with relevant expertise. The trial will hopefully gain nationwide support, and all centres in the Netherlands are cordially invited to participate.

Translated title of the contributionDutch study on the optimal treatment strategy for patients with a first or second occurrence of gastro-oesophageal variceal bleeding: The TIPS-TRUE trial
Original languageDutch (Belgium)
Pages (from-to)643-645
Number of pages3
JournalNederlands Tijdschrift voor Geneeskunde
Volume152
Issue number11
Publication statusPublished - Mar 15 2008
Externally publishedYes

ASJC Scopus Subject Areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Dutch study on the optimal treatment strategy for patients with a first or second occurrence of gastro-oesophageal variceal bleeding: The TIPS-TRUE trial'. Together they form a unique fingerprint.

Cite this